Figure 1From: Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment? Kaplan-Meier estimates of being cancer-free for BRCA1 (upper panels) and BRCA2 (lower panels) carriers: overall, stratified by menopausal stage, and by oophorectomy. Back to article page